Clinical trial
A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive…
NCT00254865 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00254865 |
|---|---|
| Title | A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers |
| Official title | A Comparative Pharmacokinetic Study of EVRA and CILEST in Healthy Female Volunteers |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Contraception, Female Contraception |
| Intervention type | Drug |
| Interventions | EVRA® transdermal contraceptive patch containing 6 mg of norelgestromin and 0.75 mg of ethinyl estradiol (versus CILEST® tablets). |
| Enrollment | 34 |
| Start date | Aug 1, 2002 |
| Completion | Mar 1, 2003 |
| First posted | Nov 17, 2005 |
| Last update posted | Jun 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: